We uncover topics around weight loss, side effects of different GLP-1 RAs, and concerns about drug access and supply, with a mainly neutral-to-positive view of GLP-1 RAs, highlighting the role of an AI-enabled pipeline to help monitor for emerging side effects, uncover public sentiment, and guide future directions for research and public health efforts
But we dont need to go under the knife, or take a $1,000-a-month drug to decrap our diet
Cloudy Pus, bacteria, or crystals think UTIs
[108] Sandoz' 2026 offering would be for diabetes only, [109] while Biocon hopes to offer generic semaglutide for diabetes and weight loss by 2027
Pancreatitis can cause severe abdominal pain, nausea, and vomiting and may require hospitalization
Lancet Diabetes Endocrinol 10(10):741760